The test analyzes a mother's blood, which has a tiny amount of DNA from the fetus. The study accurately detected each case of down syndrome, but it mistakenly identified the condition in 2 percent of the cases.
Still, it could give pregnant women a genetic testing option other than amniocentesis and CVS -- which are both invasive procedures that carry the risk of miscarriage.
The study is published in the British Medical Journal.
